Table 3.

Correlation of the CpG methylation levels of LMO2_P794, LMO2_E148, GSTM1_P266, and IL10_P325 to prenatal PTS and allergic diseases.

Prenatal factors	LMO2_P794		LMO2_E148		GSTM1_P266		IL10_P325
	UVA *	MVA #	UVA *	MVA #	UVA *	MVA #	UVA *	MVA #
Prenatal PTS	0.005	0.026	0.009	0.046	0.916	0.969	0.033	0.129
CBIgE≧0.5kU/L	0.080	0.164	0.456	0.933	0.920	0.836	0.354	0.938
Maternal atopy	0.110	0.463	0.262	0.647	0.732	0.817	0.028	0.094
Paternal atopy	0.837	0.782	0.524	0.896	0.280	0.178	0.625	0.422
Gender (male)	0.410	0.915	0.049	0.363	0.895	0.714	0.011	0.178
Preterm (<37 weeks)	0.629	0.759	0.983	0.918	0.395	0.407	0.030	0.013
18 m eczema	0.119	0.396	0.712	0.600	0.543	0.423	0.957	0.681
18 m URI > 4 times	0.393	0.383	0.213	0.289	0.713	0.883	0.843	0.980
18 m wheezing	0.433	0.368	0.972	0.877	0.987	0.736	0.467	0.552
6 y asthma	0.019	0.019	0.003	0.005	0.860	0.941	0.076	0.216
6 y rhinitis	0.389	0.088	0.271	0.015	0.646	0.480	0.898	0.204
6 y dermatitis	0.314	0.294	0.580	0.236	0.485	0.782	0.948	0.601

Notes: M, month-old; y, year-old.

^*UVA: Univariate linear regression analysis.

^#MVA: Multivariate linear regression analysis; CBIgE, cord blood immunoglobulin E; URI, upper respiratory tract infection.